Imiquimod in the treatment of breast cancer skin metastasis

Journal of Clinical Oncology

Volumn 32, Issue 8, 2014, Pages

  Henriques, Lisa ^a   Palumbo, Michael ^b   Guay, Marie Pascale ^b   Bahoric, Boris ^b   Basik, Mark ^b   Kavan, Petr ^b   Batist, Gerald ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ERIBULIN; GEMCITABINE; HYDROMORPHONE; IMIQUIMOD; LAPATINIB; OXYCODONE; PACLITAXEL; TRASTUZUMAB; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CERVICAL LYMPHADENOPATHY; DISEASE FREE INTERVAL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LUNG NODULE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MAINTENANCE CHEMOTHERAPY; MALIGNANT PLEURA EFFUSION; MULTIPLE CYCLE TREATMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RETREATMENT; SKIN BIOPSY; SKIN DEFECT; SKIN METASTASIS; SKIN PAIN; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST CANCER; BREAST TUMOR; DISEASE COURSE; FATALITY; INTRADERMAL DRUG ADMINISTRATION; METASTASIS; PAGET NIPPLE DISEASE; PAIN; PATHOLOGY; SKIN TUMOR;

ADMINISTRATION, CUTANEOUS; ADULT; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; PAIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84899659677     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.46.4883     Document Type: Article

References (16)

1. Krathen RA, Orengo IF, Rosen T: Cutaneous metastasis: A meta-analysis of data. South Med J 96:164-167, 2003 (Pubitemid 36268589)
2. Hengge UR, Roth S, Tannapfel A: Topical imiquimod to treat recurrent breast cancer. Breast Cancer Res Treat 94:93-94, 2005 (Pubitemid 41416946)
3. Hemmi H, Kaisho T, Takeuchi O, et al: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196-200, 2002 (Pubitemid 34141451)
4. Drobits B, Holcmann M, Amberg N, et al: Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest 122:575-585, 2012
5. Li VW, Li WW, Talcott KE, et al: Imiquimod as an antiangiogenic agent. J Drugs Dermatol 4:708-717, 2005
6. Huang SW, Chang CC, Lin CC, et al: Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells. J Dermatol Sci 65:170-178, 2012
7. Schön MP, Wienrich BG, Drewniok C, et al: Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod. J Invest Dermatol 122:1266-1276, 2004 (Pubitemid 38651103)
8. Smith EB, Schwartz M, Kawamoto H, et al: Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. J Urol 177:2347-2351, 2007 (Pubitemid 46726385)
9. Smits EL, Ponsaerts P, Berneman ZN, et al: The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 13:859-875, 2008
10. Hesling C, D'Incan M, Mansard S, et al: In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Br J Dermatol 150:761-767, 2004 (Pubitemid 38586231)
11. Wolf IH, Smolle J, Binder B, et al: Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 139:273-276, 2003 (Pubitemid 36330572)
12. Moussas GI, Papadopoulou AG, Christodoulaki AG, et al: Psychological and psychiatric problems in cancer patients: Relationship to the localization of the disease [in Greek]. Psychiatrike 23:46-60, 2012
13. Battie C, Verschoore M: Dermatology, cosmetic and well-being [in French]. Ann Dermatol Venereol 138:294-301, 2011
14. Moore RA, Edwards JE, Hopwood J, et al: Imiquimod for the treatment of genital warts: A quantitative systematic review. BMC Infect Dis 1:3, 2001
15. Torres A, Storey L, Anders M, et al: Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream. J Transl Med 5:7, 2007
16. Asakura M, Miura H: Imiquimod 5% cream for the treatment of nasal lesion of metastatic renal cell carcinoma. Dermatol Ther 24:375-377, 2011